ArticleBMC psychiatry2025
The burden of mental, and substance use disorders in Saudi Arabia: results from the global burden of disease study 2019.
Article in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- School-based drug prevention in Saudi Arabia: are physical education teachers prepared to act?Frontiers in public health · 2026Article
- Exploring African Community Attitudes Towards Mental Illness in Australia: A Cross-Sectional Study.Healthcare (Basel, Switzerland) · 2025Article
- Gender Differences in Type 1 Diabetes Management and Mental Health Burden: Findings from a National Survey in Saudi Arabia.Journal of clinical medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMental and substance use disorders represent a significant public health challenge worldwide. In Saudi Arabia also a high burden of disease associated with mental disorders accounted for about 7.3% of the total burden of disease in the country. This study aimed to assess the temporal trends of prevalence, incidence, years-lived with disability (YLDs), and disability-adjusted life-years (DALYs) rates due to mental and substance use disorders over a 30-year period in Saudi Arabia.
methodThe data was obtained from The Global Burden of Disease (GBD) 2019. The GBD provided inclusive and accessible epidemiological data on 369 diseases and injuries, as well as 87 risk factors, from 1990 to 2019.
resultsIn 2019, there were 5,032,669 (95%) uncertainty intervals (UI) 3·5-9·9)) adults in Saudi Arabia with mental disorder, and 166,989 with substance use disorder. The largest proportion of prevalence increase from 1990 to 2019 was in eating disorder with 9.8% (95% UI 7.03-12.6). The most significant proportion of prevalence and incidence increase from 1990 to 2019 was in opioid disorders with 41.08% change in prevalence and 36.83 in incidence. From 1990 to 2019 there was + 26.46% increase in the annual change rate of age standardized DALYs due to substance use disorders.
conclusionMental disorders have a significant negative impact on large proportion of Saudis. While substance use disorder had moderate prevalence, it has been increasing rapidly since 2016. It is crucial for health officials and policymakers to make substantial investments in mental health and substance use services to promote prevention when possible and to offer accessible treatment, care, and rehabilitation. Efforts should also focus on integrating mental and physical health services.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.